Differences in non-synuclein biomarkers between EOPD and LOPD have been reported in the literature; younger people with PD often have lower CSF tau and amyloid levels, likely reflecting a less co-pathology burden [76, 77]. This evidence concerns the gene SNCA and Parkinson disease.